A carregar...
Abundance of P-glycoprotein and other drug transporters at the human blood-brain barrier in Alzheimer’s Disease: a quantitative targeted proteomic study
The human blood-brain barrier (BBB) transporter P-glycoprotein (P-gp) can efflux amyloid-β out of the central nervous system. Amyloid-β is thought to be the causative agent for Alzheimer’s Disease (AD). Using PET imaging, we have shown that BBB P-gp activity is reduced in AD, as quantified by the in...
Na minha lista:
| Publicado no: | Clin Pharmacol Ther |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7902298/ https://ncbi.nlm.nih.gov/pubmed/32885413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.2035 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|